Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Testing effectiveness (Phase 2)UnknownNCT05420597
What this trial is testing

Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma

Who this might be right for
Laryngeal CancerHypopharyngeal Cancer
Fudan University 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT04825990
What this trial is testing

Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma
Gruppo Oncologico del Nord-Ovest 30
Large-scale testing (Phase 3)UnknownNCT00677118
What this trial is testing

Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 506
Testing effectiveness (Phase 2)UnknownNCT02729324
What this trial is testing

Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Who this might be right for
Nasopharyngeal NeoplasmsRadiodermatitis
Yun-fei Xia 136
Testing effectiveness (Phase 2)Ended earlyNCT01245985
What this trial is testing

TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors

Who this might be right for
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer
Heidelberg University 8
Not applicableUnknownNCT03689556
What this trial is testing

Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 40
Not applicableUnknownNCT05547971
What this trial is testing

Development of Intelligent Model for Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on Radio-metabolomics

Who this might be right for
Nasopharyngeal Carcinoma
Xiangya Hospital of Central South University 800
Testing effectiveness (Phase 2)UnknownNCT02902432
What this trial is testing

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

Who this might be right for
Nasopharyngeal Neoplasms
China International Medical Foundation 24
Testing effectiveness (Phase 2)Study completedNCT05020067
What this trial is testing

Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

Who this might be right for
Nasopharyngeal CarcinomaRadiation-induced Xerostomia
Sun Yat-sen University 90
Large-scale testing (Phase 3)Looking for participantsNCT06851663
What this trial is testing

Trop2-targeted immunoPET Imaging of Solid Tumors

Who this might be right for
Solid TumorSolid CarcinomaUroepithelial Carcinoma+11 more
RenJi Hospital 400
Not applicableUnknownNCT03411954
What this trial is testing

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00970502
What this trial is testing

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Who this might be right for
Cancer of the PharynxCancer of the LarynxCancer of the Neck+2 more
Johnny Kao 15
Testing effectiveness (Phase 2)UnknownNCT03639467
What this trial is testing

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma
Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04004871
What this trial is testing

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal CancerNasopharynx Cancer
Guangxi Medical University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064902
What this trial is testing

Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 48
Early research (Phase 1)Study completedNCT04870840
What this trial is testing

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

Who this might be right for
Locally Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell Carcinoma+16 more
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT04823468
What this trial is testing

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNutritional Support
Jinsheng Hong 236
Testing effectiveness (Phase 2)Active Not RecruitingNCT04862650
What this trial is testing

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+22 more
Marcelo Bonomi
Testing effectiveness (Phase 2)UnknownNCT05229315
What this trial is testing

PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaT2-3N0 or T1-2N1EBV-DNA≤4000 Copy/ml
XIANG YANQUN 45
Next Page
46